| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |